Company K Partners logo

Company K Partners

Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu

Description

Company K Partners is a prominent South Korean principal investment firm established in 2008, with a robust focus on venture capital and private equity investments. Headquartered in Ilsangu, the firm has built a diverse portfolio primarily centered around three core sectors: culture content, electronic components, and computers. This strategic specialization allows Company K Partners to leverage deep industry insights and networks within these high-growth areas. Their investment philosophy emphasizes identifying and nurturing innovative companies that demonstrate strong potential for market disruption and significant growth.

The firm manages multiple investment funds, including notable vehicles such as the K-Culture Content Fund and various K-Growth Funds. For instance, Company K Partners has been instrumental in raising and managing funds, including a significant ₩100 billion (approximately $75 million USD at current exchange rates) fund dedicated to cultural and digital content. This substantial capital base enables them to support companies across various stages of development, from early-stage startups to more mature enterprises seeking growth capital. Their extensive portfolio includes over 100 investments in a wide array of companies, reflecting their broad reach and active participation in the South Korean tech and content ecosystem.

Company K Partners' investment strategy is characterized by its flexibility and long-term perspective. They are known for their active engagement with portfolio companies, providing not just capital but also strategic guidance and operational support to help accelerate growth and achieve market leadership. Their commitment to fostering innovation within the culture content sector has been particularly impactful, contributing to the global success of Korean entertainment and digital media. Similarly, their investments in electronic components and computer technologies underscore their belief in the foundational role these sectors play in the future economy.

The firm typically deploys capital in a range that accommodates both promising early-stage ventures and established companies requiring substantial growth funding. While specific first cheque sizes can vary based on the opportunity and stage, their participation in various funding rounds, from seed to Series C and beyond, indicates a capacity to write initial checks from several hundred thousand dollars up to multi-million dollar figures.

Investor Profile

Company K Partners has backed more than 29 startups, with 12 new investments in the last 12 months alone. The firm has led 3 rounds, about 10% of its total and boasts 18 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in South Korea, United States, Germany.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Biotechnology.
  • Led 1 rounds in the past year.
  • Typical check size: $500K – $10M.

Stage Focus

  • Series B (34%)
  • Series A (21%)
  • Seed (17%)
  • Series D (10%)
  • Series Unknown (10%)
  • Series C (7%)

Country Focus

  • South Korea (90%)
  • United States (7%)
  • Germany (3%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Biotechnology
  • Pharmaceutical
  • Apps
  • Internet
  • Marketplace
  • E-commerce
  • Biopharma
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Company K Partners frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Altos Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
LB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
SBVA
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 5
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Atinum Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4

What are some of recent deals done by Company K Partners?

Illimis Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJul 14, 2025
Amount Raised: $42,004,389
HydroXpand

Daejeon, Taejon-jikhalsi, South Korea

HydroXpand is an innovative developer and manufacturer specializing in the design and production of anion exchange membrane.

Clean EnergyEnergy StorageRenewable Energy
SeedMay 19, 2025
MADDE

Seoul, Seoul-t'ukpyolsi, South Korea

MADDE specializes in three-dimensional (3D) printing technology.

3D PrintingTechnical Support
Series AApr 15, 2025
Amount Raised: $7,700,411
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Imagoworks

Seocho, Seoul-t'ukpyolsi, South Korea

Imagoworks specializes in artificial intelligence and cloud-based 3D dental and medical software.

Artificial Intelligence (AI)Cloud ManagementMedicalSoftware
Series CDec 31, 2024
Amount Raised: $15,616,415
HyperAccel

Seoul, Seoul-t'ukpyolsi, South Korea

HyperAccel provides hardware solutions for developing AI applications.

HardwareManufacturingSemiconductor
Series ADec 18, 2024
Amount Raised: $37,835,796
Baropharm

Soeul, Ch'ungch'ong-namdo, South Korea

Baropharm is an online e-commerce platform that sells pharmaceutical products for improved individual care.

BiopharmaE-CommercePharmaceutical
Series UnknownNov 28, 2024
Amount Raised: $13,648,053
QuTope

Daejeon, Taejon-jikhalsi, South Korea

QuTope is a manufacturer of chemical and biomaterials.

BiotechnologyChemicalManufacturing
Series ANov 19, 2024
Amount Raised: $3,588,544
Makestar

Seoul, Seoul-t'ukpyolsi, South Korea

Makestar is a platform that provides K-culture content and information.

CrowdfundingInternetMedia and Entertainment
Series DOct 8, 2024
Amount Raised: $22,371,168
Bio Design Lab

Pohang, Kyongsang-bukto, South Korea

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

BiopharmaBiotechnologyGeneticsTest and Measurement
Series BOct 7, 2024
Amount Raised: $4,987,450